QS Investors’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $4.55M | Hold |
80,090
| – | – | 0.05% | 248 |
|
|
2021
Q1 | $6M | Buy |
80,090
+74,590
| +1,356% | +$5.58M | 0.07% | 210 |
|
|
2020
Q4 | $476K | Hold |
5,500
| – | – | 0.01% | 805 |
|
|
2020
Q3 | $337K | Sell |
5,500
-19,350
| -78% | -$1.19M | ﹤0.01% | 880 |
|
|
2020
Q2 | $1.03M | Buy |
24,850
+23,250
| +1,453% | +$967K | 0.01% | 712 |
|
|
2020
Q1 | $46K | Hold |
1,600
| – | – | ﹤0.01% | 1419 |
|
|
2019
Q4 | $118K | Hold |
1,600
| – | – | ﹤0.01% | 1338 |
|
|
2019
Q3 | $225K | Hold |
1,600
| – | – | ﹤0.01% | 1175 |
|
|
2019
Q2 | $293K | Hold |
1,600
| – | – | ﹤0.01% | 1118 |
|
|
2019
Q1 | $255K | Sell |
1,600
-5
| -0.3% | -$797 | ﹤0.01% | 1149 |
|
|
2018
Q4 | $154K | Hold |
1,605
| – | – | ﹤0.01% | 1212 |
|
|
2018
Q3 | $227K | Hold |
1,605
| – | – | ﹤0.01% | 1171 |
|
|
2018
Q2 | $251K | Buy |
1,605
+800
| +99% | +$125K | ﹤0.01% | 1133 |
|
|
2018
Q1 | $130K | Hold |
805
| – | – | ﹤0.01% | 1315 |
|
|
2017
Q4 | $133K | Buy |
805
+5
| +0.6% | +$826 | ﹤0.01% | 1332 |
|
|
2017
Q3 | $50K | Hold |
800
| – | – | ﹤0.01% | 1527 |
|
|
2017
Q2 | $64K | Hold |
800
| – | – | ﹤0.01% | 1460 |
|
|
2017
Q1 | $57K | Buy |
+800
| New | +$57K | ﹤0.01% | 1483 |
|